Cargando…
Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
Nephrogenic systemic fibrosis (NSF) is a relatively new entity, first described in 1997. Few cases have been reported, but the disease has high morbidity and mortality. To date it has been seen exclusively in patients with renal dysfunction. There is an emerging link with intravenous injection of ga...
Autores principales: | Mendichovszky, Iosif A., Marks, Stephen D., Simcock, Clare M., Olsen, Øystein E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292494/ https://www.ncbi.nlm.nih.gov/pubmed/17943276 http://dx.doi.org/10.1007/s00247-007-0633-8 |
Ejemplares similares
-
Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009) -
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
por: Bennett, Charles L., et al.
Publicado: (2012) -
NEPHROGENIC SYSTEMIC FIBROSIS: TIME FOR THE REQUIEM?
por: Panda, Saumya
Publicado: (2011) -
A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
por: Do, Jong Geol, et al.
Publicado: (2012) -
An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis
por: Zhang, Bin, et al.
Publicado: (2015)